by Valeo Pharma | Jun 29, 2021 | News Release
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, QC – June 29, 2021 – Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, is pleased to announce the closing...
by Valeo Pharma | Jun 23, 2021 | News Release
MONTREAL, QUEBEC , June 23, 2021 – Valeo Pharma Inc. (CSE:VPH, OTCQB: VPHIF, FSE:VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, announced today that it will report its financial results and highlights for the second quarter ended April 30, 2021 on...
by Valeo Pharma | Jun 23, 2021 | News Release
MONTREAL, QUEBEC , June 23, 2021 – Valeo Pharma Inc. (CSE:VPH, OTCQB: VPHIF,FSE:VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, announcedtoday that it will report its financial results and highlights for the second quarter ended April30, 2021 on...
by Valeo Pharma | Jun 22, 2021 | News Release
Product shipments have commenced across Canada National respiratory sales force recruitment well advanced, field deployment on-going Private and public reimbursement coverage progressing Nelly Komari, joins Valeo as Senior Vice President Scientific & Medical...
by Valeo Pharma | Jun 8, 2021 | News Release
MONTREAL, QC – June 8, 2021 – Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, is pleased to announce that it has entered into an agreement with Research Capital Corporation...
by Valeo Pharma | Jun 1, 2021 | News Release
Private payer health plan coverage in Canada for Enerzair Breezhaler and Atectura Breezhaler has reached 80% Reimbursement proceedings with publicly funded health plans ready to commence MONTREAL, QUEBEC , June 1, 2021 – Valeo Pharma Inc. (CSE:VPH, OTCQB: VPHIF, FSE:...
